BioFactura and CuraTeQ Sign Exclusive License for BFI-751—A Biosimilar to Stelara
Frederick, Maryland (PRWEB) July 10, 2023 -- BioFactura, Inc. today announced that CuraTeQ Biologics Private Limited, a wholly owned subsidiary of Aurobindo
Stay updated with breaking news from Biomanufacturing Platform. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Frederick, Maryland (PRWEB) July 10, 2023 -- BioFactura, Inc. today announced that CuraTeQ Biologics Private Limited, a wholly owned subsidiary of Aurobindo
On June 30, 2023, EuropaBio announced that it “set[] in stone the first European recommendations on biomanufacturing with the publication of its Biomanufacturing Policy Summit 2023...
EuropaBio announced on November 14, 2022, a new cross-sectoral Biomanufacturing Platform. EuropaBio states that the Platform has the mission to represent biomanufacturing at the highest...
BioFactura Funded $13 Million Contract Option for its Smallpox Biodefense Therapeutic Share Article Confirms BARDA support of critical medical countermeasure development Dr. Darryl Sampey, President and CEO of BioFactura, stated, “Funding of our first option confirms the commitment of BARDA to support development of this important product. We look forward to continuing our close collaboration with BARDA as we move into the pathway to FDA approval." FREDERICK, Md. (PRWEB) February 19, 2021 BioFactura, Inc. today announced a con...